Selected research
Industry Research
Codeine Tablet Industry Research Report 2026
Market perspective
The global Codeine Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Codeine Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Codeine Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Codeine Tablet include TEVA, Johnson & Johnson, Novartis, Mylan, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Codeine Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Codeine Tablet Market by Company
TEVA
Johnson & Johnson
Novartis
Mylan
Taiji
Sanofi Aventis
Pharmaceutical Associates
Medreich
Mallinckrodt
Lannett Company
Laboratoire Riva
Hikma
Cipla
Aristo Pharma GmbH
Apotex
Codeine Tablet Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Tablet Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Codeine Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Codeine Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Codeine Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-ingredient Codeine
- Multi-ingredient Medications
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- TEVA
- Johnson & Johnson
- Novartis
- Mylan
- Taiji
- Sanofi Aventis
- Pharmaceutical Associates
- Medreich
- Mallinckrodt
- Lannett Company
- Laboratoire Riva
- Hikma
- Cipla
- Aristo Pharma GmbH
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Codeine Tablet Market Size (2021-2032)
- 2.2.2 Global Codeine Tablet Sales (2021-2032)
- 2.2.3 Global Codeine Tablet Market Average Price (2021-2032)
- 2.3 Codeine Tablet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single-ingredient Codeine
- 2.3.3 Multi-ingredient Medications
- 2.4 Codeine Tablet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Narcotic Analgesic
- 2.4.3 Antitussive
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Codeine Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Codeine Tablet Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Codeine Tablet Revenue of Manufacturers (2021-2026)
- 3.4 Global Codeine Tablet Average Price by Manufacturers (2021-2026)
- 3.5 Global Codeine Tablet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Codeine Tablet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Codeine Tablet, Product Type & Application
- 3.8 Global Manufacturers of Codeine Tablet, Established Date
- 3.9 Global Codeine Tablet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 TEVA
- 4.1.1 TEVA Company Information
- 4.1.2 TEVA Business Overview
- 4.1.3 TEVA Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 TEVA Codeine Tablet Product Portfolio
- 4.1.5 TEVA Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Codeine Tablet Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Codeine Tablet Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Codeine Tablet Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Taiji
- 4.5.1 Taiji Company Information
- 4.5.2 Taiji Business Overview
- 4.5.3 Taiji Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taiji Codeine Tablet Product Portfolio
- 4.5.5 Taiji Recent Developments
- 4.6 Sanofi Aventis
- 4.6.1 Sanofi Aventis Company Information
- 4.6.2 Sanofi Aventis Business Overview
- 4.6.3 Sanofi Aventis Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sanofi Aventis Codeine Tablet Product Portfolio
- 4.6.5 Sanofi Aventis Recent Developments
- 4.7 Pharmaceutical Associates
- 4.7.1 Pharmaceutical Associates Company Information
- 4.7.2 Pharmaceutical Associates Business Overview
- 4.7.3 Pharmaceutical Associates Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pharmaceutical Associates Codeine Tablet Product Portfolio
- 4.7.5 Pharmaceutical Associates Recent Developments
- 4.8 Medreich
- 4.8.1 Medreich Company Information
- 4.8.2 Medreich Business Overview
- 4.8.3 Medreich Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Medreich Codeine Tablet Product Portfolio
- 4.8.5 Medreich Recent Developments
- 4.9 Mallinckrodt
- 4.9.1 Mallinckrodt Company Information
- 4.9.2 Mallinckrodt Business Overview
- 4.9.3 Mallinckrodt Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mallinckrodt Codeine Tablet Product Portfolio
- 4.9.5 Mallinckrodt Recent Developments
- 4.10 Lannett Company
- 4.10.1 Lannett Company Company Information
- 4.10.2 Lannett Company Business Overview
- 4.10.3 Lannett Company Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lannett Company Codeine Tablet Product Portfolio
- 4.10.5 Lannett Company Recent Developments
- 4.11 Laboratoire Riva
- 4.11.1 Laboratoire Riva Company Information
- 4.11.2 Laboratoire Riva Business Overview
- 4.11.3 Laboratoire Riva Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Laboratoire Riva Codeine Tablet Product Portfolio
- 4.11.5 Laboratoire Riva Recent Developments
- 4.12 Hikma
- 4.12.1 Hikma Company Information
- 4.12.2 Hikma Business Overview
- 4.12.3 Hikma Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hikma Codeine Tablet Product Portfolio
- 4.12.5 Hikma Recent Developments
- 4.13 Cipla
- 4.13.1 Cipla Company Information
- 4.13.2 Cipla Business Overview
- 4.13.3 Cipla Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cipla Codeine Tablet Product Portfolio
- 4.13.5 Cipla Recent Developments
- 4.14 Aristo Pharma GmbH
- 4.14.1 Aristo Pharma GmbH Company Information
- 4.14.2 Aristo Pharma GmbH Business Overview
- 4.14.3 Aristo Pharma GmbH Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Aristo Pharma GmbH Codeine Tablet Product Portfolio
- 4.14.5 Aristo Pharma GmbH Recent Developments
- 4.15 Apotex
- 4.15.1 Apotex Company Information
- 4.15.2 Apotex Business Overview
- 4.15.3 Apotex Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Apotex Codeine Tablet Product Portfolio
- 4.15.5 Apotex Recent Developments
5 Global Codeine Tablet Market Scenario by Region
- 5.1 Global Codeine Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Codeine Tablet Sales by Region: 2021-2032
- 5.2.1 Global Codeine Tablet Sales by Region: 2021-2026
- 5.2.2 Global Codeine Tablet Sales by Region: 2027-2032
- 5.3 Global Codeine Tablet Revenue by Region: 2021-2032
- 5.3.1 Global Codeine Tablet Revenue by Region: 2021-2026
- 5.3.2 Global Codeine Tablet Revenue by Region: 2027-2032
- 5.4 North America Codeine Tablet Market Facts & Figures by Country
- 5.4.1 North America Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Codeine Tablet Sales by Country (2021-2032)
- 5.4.3 North America Codeine Tablet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Codeine Tablet Market Facts & Figures by Country
- 5.5.1 Europe Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Codeine Tablet Sales by Country (2021-2032)
- 5.5.3 Europe Codeine Tablet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Codeine Tablet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Codeine Tablet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Codeine Tablet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Codeine Tablet Market Facts & Figures by Country
- 5.7.1 South America Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Codeine Tablet Sales by Country (2021-2032)
- 5.7.3 South America Codeine Tablet Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Codeine Tablet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Codeine Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Codeine Tablet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Codeine Tablet Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Codeine Tablet Sales by Type (2021-2032)
- 6.1.1 Global Codeine Tablet Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Codeine Tablet Sales Market Share by Type (2021-2032)
- 6.2 Global Codeine Tablet Revenue by Type (2021-2032)
- 6.2.1 Global Codeine Tablet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Codeine Tablet Revenue Market Share by Type (2021-2032)
- 6.3 Global Codeine Tablet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Codeine Tablet Sales by Application (2021-2032)
- 7.1.1 Global Codeine Tablet Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Codeine Tablet Sales Market Share by Application (2021-2032)
- 7.2 Global Codeine Tablet Revenue by Application (2021-2032)
- 7.2.1 Global Codeine Tablet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Codeine Tablet Revenue Market Share by Application (2021-2032)
- 7.3 Global Codeine Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Codeine Tablet Value Chain Analysis
- 8.1.1 Codeine Tablet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Codeine Tablet Production Mode & Process
- 8.2 Codeine Tablet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Codeine Tablet Distributors
- 8.2.3 Codeine Tablet Customers
9 Global Codeine Tablet Analyzing Market Dynamics
- 9.1 Codeine Tablet Industry Trends
- 9.2 Codeine Tablet Industry Drivers
- 9.3 Codeine Tablet Industry Opportunities and Challenges
- 9.4 Codeine Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst